History and Recent Advances in Coronavirus Discovery

Abdul-Fattah, Sora; Pal, Aman; Kaka, Nagham; Kakodkar, Pramath

doi:10.1007/7653_2020_47

Cited by 5 publications

(2 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This disease turns life-threatening if people are suffering from SARS. A total of 774 people was died from 2002 to 2014, according to the last reported case (Abdul-Fattah et al 2021).…”

Section: History and Classificationmentioning

confidence: 99%

Current challenges in different approaches to control COVID-19: a comprehensive review

et al. 2022

View full text Add to dashboard Cite

Background The World Health Organization declared the outbreak of the novel coronavirus (COVID-19) as a global health emergency on January 30, 2020, and as a pandemic disease on March 11, 2020. This review highlights the international situation, risk factors, and related protections to be taken as prerequisite measures and probable treatment options for the COVID-19-infected population in the current scenario. Main text The SARS-CoV-2 viruses and their variants caused mild-to-severe respiratory tract infection and used airborne pathways as a way of contagion. Human-to-human transmission led to an exponential growth in the rise in the number of cases making it a real burden to immobilize the rapid spread of the virus while asymptomatic patients created ambiguity for confirmation in the community. It was clear from the case studies of patients that most of them were asymptomatic but still vulnerable to the people around, and hence, in a flash, many countries around the globe went into a complete lockdown, influencing the economy and thrashing industrial outputs. On the other hand, numerous researches were made to counteract the spread through studies in antiviral therapy, immune-based therapy, vaccination development, and natural remedies. Conclusion Although exploration for a specific drug required for the COVID-19 treatment is under extensive research worldwide and some of them are in clinical trial now. Virtual drug library screening is one of the current techniques for repurposing accessible compounds. This review could provide beneficial information about the potential current and future treatment strategies to treat the pandemic COVID-19 infection.

show abstract

“…This disease turns life-threatening if people are suffering from SARS. A total of 774 people was died from 2002 to 2014, according to the last reported case (Abdul-Fattah et al 2021).…”

Section: History and Classificationmentioning

confidence: 99%

Current challenges in different approaches to control COVID-19: a comprehensive review

et al. 2022

View full text Add to dashboard Cite

show abstract

“…However, in the last 60 years, there has been a particular interest in their relationship with human diseases, thanks to the discovery of the first two human strains, OC43 [ 3 , 4 ] and 229E [ 5 ]. Subsequently, this interest became more and more consolidated with the discovery of the so-called pathogenic coronaviruses [ 6 , 7 , 8 , 9 ] and, more appropriately, with the appearance of the pandemic viruses SARS-CoV-1 [ 10 ], MERS-CoV [ 11 ], and SARS-CoV-2 [ 12 ].…”

Section: Introductionmentioning

confidence: 99%

Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43

Fuochi

Floresta

Emma

et al. 2023

Viruses

View full text Add to dashboard Cite

It is known that the spike protein of human coronaviruses can bind to a secondary receptor, or coreceptor, to facilitate the virus entry. While HCoV-229E uses human aminopeptidase N (hAPN) as a receptor, HCoV-OC43 binds to 9-O-acetyl-sialic acid (9-O-Ac-Sia), which is linked in a terminal way to the oligosaccharides that decorate glycoproteins and gangliosides on the surface of the host cell. Thus, evaluating the possible inhibitory activity of heparan sulfate, a linear polysaccharide found in animal tissues, and enoxaparin sodium on these viral strains can be considered attractive. Therefore, our study also aims to evaluate these molecules’ antiviral activity as possible adsorption inhibitors against non-SARS-CoV. Once the molecules’ activity was verified in in vitro experiments, the binding was studied by molecular docking and molecular dynamic simulations confirming the interactions at the interface of the spike proteins.

show abstract

A Review of Pathology and Analysis of Approaches to Easing Kidney Disease Impact: Host–Pathogen Communication and Biomedical Visualization Perspective

Pizon

Hampal

et al. 2023

Advances in Experimental Medicine and Biology

View full text Add to dashboard Cite

History and Recent Advances in Coronavirus Discovery

Cited by 5 publications

References 45 publications

Current challenges in different approaches to control COVID-19: a comprehensive review

Current challenges in different approaches to control COVID-19: a comprehensive review

Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43

A Review of Pathology and Analysis of Approaches to Easing Kidney Disease Impact: Host–Pathogen Communication and Biomedical Visualization Perspective

Contact Info

Product

Resources

About